How a drug is delivered is a great focus of medicine today. The oral drug delivery market is the largest segment of the total drug delivery market and it is the oldest. It is also the preferred method of administering medications by both healthcare personnel and patients. The oral drug delivery market is segmented into five main categories.
- Controlled-release/sustained-release formulations
- Delayed-release and modified-release formulations
- Pulsatile-release formulations
- Taste-mask formulations
- Microemulsion and other formulations
However, not all drugs can be delivered orally.
Therefore injection through needle or through needle-free jet delivery, pulmonary (respiratory / lung), transdermal (under the skin) are valid delivery options and are being used with many of the new drug therapies available.
As drugs get more complex, the delivery mechanisms are also become more complicated. Biopharmaceutical therapies will require different drug mechanisms. Reports in this section address the ways of delivering drugs and the market impact of those systems.
All reports in Drug Delivery
|
Oral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth
4/30/2012 | published by: GBI Research
... Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth”. The report focuses on the current scenario of orally administered drugs. Key segment of orally administered drugs ...
|
more...
|
$3,500.00
|
|
Herpes Market to 2018 - Genericization Compels Competitors Seeking Differentiation to Adopt Novel Drug Delivery Technologies
4/1/2012 | published by: GBI Research
... Technologies finds that the global herpes market is an attractive one, and is expected to witness growth during the forecast period and to provide good opportunities for investors. The expected high growth is attributed to ...
|
more...
|
$3,500.00
|
|
Implantable Medical Devices
3/1/2012 | published by: Freedonia Group Inc
... expected to be strong over the forecast period. Next generation devices have increased confidence in orthopedic, cardiovascular and other implants. Demand will also benefit from the lack of alternative treatments for many chronic disorders and ...
|
more...
|
$5,100.00
|
|
Global Inhaled Antibiotics Market 2011-2015
2/29/2012 | published by: Infiniti Research Limited
... Inhaled Antibiotics market has also been witnessing the trend of huge investment in R&D of drugs by the vendors. However, the high cost of inhaled antibiotics could pose a challenge to the growth of this ...
|
more...
|
$1,500.00
|
|
Drug Delivery: Surveying the Global Competitive Landscape
2/9/2012 | published by: Espicom Healthcare Intelligence
... exciting development companies with novel drug delivery technologies Find out more about the competitive environment Profile the leading drug delivery companies as they battle for supremacy Understand the trends that are driving the sector onwards
|
more...
|
$1,040.00
|
|
Nanotechnology for Drug Delivery: Global Market for Nanocarriers
2/7/2012 | published by: Cientifica Ltd.
... nanocarriers respectively, although developing new targeted delivery mechanisms may allow more value to be created for companies and entrepreneurs. Of the 10 nanocarrier technologies studied, liposomes and gold nanocarriers account for 45% of the total ...
|
more...
|
$1,599.00
|
|
Needle Array Drug Delivery Systems
2/1/2012 | published by: Greystone Research Associates
... and by the need for safer, more reliable drug products that improve compliance. For drugs designed to be delivered across the skin, needle arrays are viewed as an approach that addresses these key healthcare objectives. ...
|
more...
|
$2,850.00
|
|
Drug Delivery Technologies: Commercial Prospects 2012-2022
1/31/2012 | published by: Visiongain
... commercial opportunities for improved drug delivery exist. You discover sales predictions to 2022 at world market, submarket, application and national level. In particular, our report forecasts six submarkets to 2022, showing you potential revenues: Oral ...
|
more...
|
$2,642.00
|
|
Freedonia Focus on Drug Delivery Products: United States
1/31/2012 | published by: Freedonia Focus
... and global overview, market environment, product and application forecasts, industry composition and leading participants. Product segments include oral, parenteral and other drug delivery products; application segments cover central nervous system (CNS), respiratory, hormones and related, ...
|
more...
|
$600.00
|
|
Dosing And Dispensing Drives Home And Personal Care Closures
1/23/2012 | published by: Euromonitor International
... Adding such value is especially important in mature developed economies, where growth is increasingly hard to come by. Nevertheless, plastic dispensing closures will still account for most growth, with emerging regions and BRIC countries to ...
|
more...
|
$2,000.00
|
|
Nanotechnology in Medical Applications: The Global Market
1/17/2012 | published by: BCC Research
... Important trends are identified and sales forecasts by product categories and major country markets are provided through 2016; these are based on industry sources and considered assessment of the regulatory environment, healthcare policies, demographics, and ...
|
more...
|
$4,850.00
|
|
Nanotechnology in Drug Delivery: Global Markets
1/16/2012 | published by: Cientifica Ltd.
... 2021. This sector will therefore represent approximately 15% of the global nanotechnology market in 2021. Healthcare offers the greatest opportunity to add value to nanomaterials and China is the fastest-growing market sector, according to Cientifica.
|
more...
|
$1,599.00
|
|
US Market for Implantable Medical Devices
1/1/2012 | published by: Taiyou Research
... especially in the cardiac implant segment, growth will remain strong. Gains will be invigorated by the development of next generation devices based on new technologies and improved materials. Spinal implants, cardiac stents and orthobiologics will ...
|
more...
|
$450.00
|
|
Pulmonary Drug Delivery Systems: Technologies and Global Markets
1/1/2012 | published by: BCC Research
... at a compound annual growth rate (CAGR) of 14.3%. The market for metered dose inhalers (MDIs) was $12.5 billion in 2010 and will reach $14.4 billion by the end of 2011. BCC forecasts this market ...
|
more...
|
$4,850.00
|
|
Outsourcing in Drug Development: The Contract CRO, Clinical Trial Lab and EDC Market
1/1/2012 | published by: Kalorama Information
... outsource stages of development, and over the years Kalorama Information has observed this process. In past editions of our outsourcing market studies, we found that outsourcing moved from "should" to "must." for manufacturers. This trend ...
|
more...
|
$3,995.00
|
|
Drug Delivery Systems
1/1/2012 | published by: Freedonia Group Inc
... pharmaceutical formulations and administration devices that advance the nature of therapy for autoimmune conditions, cancer, heart disease, neurological disorders and other debilitating health problems. Included in this group are human monoclonal antibodies, polymer encapsulated nanomedicines ...
|
more...
|
$4,800.00
|
|
Drug Eluting Balloons (DEB) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
12/5/2011 | published by: GlobalData
... key data, information and analysis on the global drug eluting balloons market. The report provides market landscape, competitive landscape and market trends information on the drug eluting balloons market. The report provides comprehensive information on ...
|
more...
|
$3,500.00
|
|
Nanotechnology in Drug Delivery 2011-2021
11/14/2011 | published by: Cientifica Ltd.
... cancer is one of the most commonly cited nano-healthcare benefits. Cientifica’s report, Nanotechnology in Drug Delivery 2011, gives a comprehensive analysis and geographic breakdown of the current nanotechnology drug delivery market and its most relevant ...
|
more...
|
$4,000.00
|
|
Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
11/3/2011 | published by: GlobalData
... and Market Forecasts to 2017” provides key data, information and analysis on the global implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market. The report provides market landscape, competitive landscape and market trends information on ...
|
more...
|
$3,500.00
|
|
Active Transdermal Delivery Systems
10/15/2011 | published by: Greystone Research Associates
... and business strategies Charts product sales data, market share, and forecasts to 2015 Profiles active transdermal delivery companies, their product development activities, business strategies, and corporate alliances and affiliations Assesses the importance of pharma-device alliances ...
|
more...
|
$2,850.00
|
|
Freedonia Focus on Transdermal & Implantable Drug Delivery Systems
9/30/2011 | published by: Freedonia Focus
... product and end-use forecasts, industry composition and leading participants. Product segments cover transdermal patches (central nervous system (CNS) patches and other transdermal patches) and implantable systems (drug-eluting stents and other drug implants). End-use applications include ...
|
more...
|
$600.00
|
|
Drug Delivery Device Market to 2017 - Metered Dose Inhalers and Infusion Pumps to be Key Revenue Generators
9/30/2011 | published by: GBI Research
... to be Key Revenue Generators” provides key data, information and analysis on the global drug delivery device market. The report provides the market landscape, competitive landscape and market trend information on four drug delivery device ...
|
more...
|
$3,500.00
|
|
Emerging Drug Delivery Technologies & Strategies - Players, Pipelines & Partnerships
9/12/2011 | published by: Espicom Healthcare Intelligence
An examination of trends and advances in the three major drug delivery sectors Unique sales forecasts to 2020 for key products Critical analyses of 58 specialist developers driving the drug delivery market onwards
|
more...
|
$2,265.00
|
|
Companion Diagnostics
9/1/2011 | published by: Global Industry Analysts
... period 2008 through 2017. The report profiles 101 companies including many key and niche players such as Abbott Laboratories, Abbott Molecular, bioMérieux, Clarient Inc., LabCorp, Merck & Co. Inc., Myriad Genetics, Inc., Power3 Medical Products, ...
|
more...
|
$4,200.00
|
|
Market for Drug Delivery Systems in the US
9/1/2011 | published by: Taiyou Research
... share is expected to be produced by oral drugs and parenteral or injectable drug delivery systems are expected to grow at a rapid speed as well, especially in cancer applications. The fastest growth in the ...
|
more...
|
$350.00
|
